SMSN 969.0 0.7277% TYT 2786.5 4.8542% SMSD 810.0 0.4963% SMSN 964.0 0.2079% RIGD 65.3 2.9968% RIGD 63.4 5.6667% SHEL 2443.0 -0.6103% AZN 10618.0 0.874% BHP 1815.0 0.9455% HSBA 855.6 2.6268% ULVR 4687.0 -0.2554% CYPC 39.6 -2.4631% RIO 4546.5 0.4751% LLPC 1.548 -99.0% DGED 110.88 -0.1066% BP 353.2 -2.4309% SBID 95.4 0.0% DGE 2058.0 -0.5797% GSK 1432.0 1.6324% REL 4002.0 1.0606%
SMSN 969.0 0.7277% TYT 2786.5 4.8542% SMSD 810.0 0.4963% SMSN 964.0 0.2079% RIGD 65.3 2.9968% RIGD 63.4 5.6667% SHEL 2443.0 -0.6103% AZN 10618.0 0.874% BHP 1815.0 0.9455% HSBA 855.6 2.6268% ULVR 4687.0 -0.2554% CYPC 39.6 -2.4631% RIO 4546.5 0.4751% LLPC 1.548 -99.0% DGED 110.88 -0.1066% BP 353.2 -2.4309% SBID 95.4 0.0% DGE 2058.0 -0.5797% GSK 1432.0 1.6324% REL 4002.0 1.0606%

Markets Rally Amid ECB Rate Cut & UK Business Gloom as Tariff Threats Stir Uncertainty:

By: Team Kalkine | Jan 31, 2025 | Read Time : 10 Mins
Markets Rally Amid ECB Rate Cut & UK Business Gloom as Tariff Threats Stir Uncertainty:

Image Source : Krish Capital Pty Ltd

Index Update: The FTSE 100 index, a key benchmark index for the London stock exchange, went up around 0.34% on 31 January 2025. Utilities, Energy & Industrials sector has witnessed a substantial growth. Technology & Basic Materials sector faced a minor decline. 

Macro Update:  British business confidence fell for the fifth consecutive month in January, with the Lloyds Bank Business Barometer dropping two points to 37%, its lowest level in a year, reflecting concerns over a £25 billion tax increase announced in October. Despite a 16% decline in 2024 profits, Shell's shares rose as it increased its dividend by 4% and announced a $3.5 billion share buyback, marking the 13th consecutive quarter of repurchases. The NHS will introduce a cutting-edge gene therapy for sickle cell disease, signaling progress in healthcare. Meanwhile, the FTSE 100 hit a record high of 8,646.88 points, driven by strong corporate earnings and a surge in precious metal miners, with Endeavour Mining jumping 7.2% following its production results. 

Top Market Movers: Among top gainers on FTSE 100 index, Smiths Group PLC (LSE: SMIN) witnessed a rise of 11.53% followed by Next PLC (LSE: NXT) which gained around 2.65%. 

Commodity Update: On Friday, tariff concerns drove the dollar and gold prices up. U.S. economic growth data for Q4 showed a slowdown yet remained strong enough for investors to anticipate gradual interest rate cuts by the Federal Reserve this year. The market is now awaiting the December U.S. personal consumption expenditures (PCE) price index report, a key inflation measure for the Fed. In commodity markets, gold rose 0.13% to $2,848.90, silver gained 0.58% to $32.68, while copper dropped 0.25% to $9,099.00. Brent crude rose 0.21%, closing at $76.33 amid tariff threats affecting U.S. imports from Mexico and Canada. 

Our Stance: U.S. President Donald Trump's announcement of a potential 25% tariff on Canadian and Mexican oil imports has stirred market uncertainty, contingent on oil prices and bilateral relations. Asian shares fluctuated, influenced by South Korea's tech stock movements and mixed reactions to central bank decisions—the Federal Reserve maintaining steady rates while the European Central Bank cut rates. Despite initial volatility from Trump's tariff announcement, U.S. stocks ended higher, bolstered by positive earnings from Tesla, even as Microsoft provided a lackluster outlook. Meanwhile, U.S. 10-year Treasury yields dipped to a six-week low following the ECB's rate cut but rebounded on signs of economic resilience in late 2024. The interplay of tariff threats, central bank actions, and mixed corporate earnings suggests a cautious yet resilient market outlook. 

FTSE 100 

The FTSE 100 closed at 8,646.88 on Thursday, rising 1.04% and forming a bullish candlestick pattern. The index remains above the 21-period Simple Moving Average (SMA), indicating a positive short-term outlook. With the 50-period SMA providing strong support, the upward momentum is expected to continue. The Relative Strength Index (RSI) stands at 72.90, signaling strong bullish momentum without reaching overbought levels, suggesting room for further buying pressure. These technical factors point to continued growth, making the FTSE 100 an attractive prospect for short-term investors. On the weekly chart, the FTSE 100 held steady, closing at 8,502.35, a slight 0.03% decline. It remains well above the 50-period SMA, currently at 8,167.15, and key support lies at 7,932. Resistance is seen at 8,700, and a break above this level could signal stronger bullish momentum, potentially eyeing the next resistance at 8,800. On the other hand, a move below 8,020 could raise concerns of further downside risk. Investors should focus on these levels to gauge the index’s potential price action in the coming weeks. 

A screenshot of a computer

Description automatically generated

Data Source - Refinitiv 


Disclaimer- This article has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine. Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate to your objectives, financial situation and needs before acting upon it. There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product. Please note past performance is neither an indicator nor a guarantee of future performance. You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice/information in this article or on the Kalkine website. Not all investments are appropriate for all people. The information in this article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its articles, newsletters and websites. All information represents our views at the date of publication and may change without notice. Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this article, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law. Please also read our Terms & Conditions and Financial Services Guide for further information. On the date of publishing this article (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures. Some of the images/music that may be used in the article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the article unless stated otherwise. The images/music that may be used in the article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary. Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions